Daré Bioscience Receives U.S. Patent For Its Pharmaceutical Compositions Formulated For Topical Application Comprising Lopinavir, Ritonavir To Treat Cervical Pathologies

Daré Bioscience, Inc. has been granted U.S. Patent No. 12,678,439 for its pharmaceutical compositions that utilize lopinavir and ritonavir for topical treatment of HPV-related cervical pathologies. This patent aims to enhance women's health solutions by providing a new therapeutic option for cervical disorders.